The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...

The NTAGI has approved both vaccines, but has not recommended the government to put those in the immunisation drive, people in the know tol...

Biocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...

The company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's D...

Corbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...

The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

The government had estimated that Biological would account for 300 million jabs from August to December.

While the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely ti...

The approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...

The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...

Providence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...

It is unclear why J&J wants to conduct a bridging trial in India despite regulations in India allowing easy access to vaccines that have re...

As per the ICMR , Biological E is testing a two-dose vaccine. Similar to Bharat Biotech’s Covaxin, Biological E’s vaccine under trial presc...

India may have to wait for bridging trialJ&J’s deal with Biological E is a global supply agreement and the company will be tapped to meet c...

Biological E has tied up with an undisclosed company and will be conducting the trials. The announcement about the tie up is likely to be m...

This division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.